1 filter applied
Evidence in focus: IODOSORB™ 0.9% Cadexomer Iodine Medicated Sheet...
Stuermer EK, et al. Front Microbiol (2021). Sep 2021
Evidence in focus: Use of the IODOSORB™ Cadexomer Iodine Range†...
Woo K, et al. Int Wound J (2021). May 2021
Practical hints and tips for understanding and managing infected...
Dr. Caroline Dowsett and Dr. Kevin Woo. Feb 2021
The new way: A route to more effective infection management (Spanish)
Dr. Caroline Dowsett, Dr. Alison Garten, Dr. Kevin Woo. Feb 2021
The new way: A route to more effective infection management (Italian)
Evidence in focus: INFOGRAPHIC: Effective management of biofilms and...
GLOBAL CLINICAL & MEDICAL AFFAIRS, SMITH+NEPHEW. Jan 2021
Dr Caroline Dowsett. Nov 2020
Sign in or Join
The new way: A route to more effective infection management
Evidence in focus: IODOFLEX™ 0.9% Cadexomer Iodine Dressing killed...
Phillips PL, et al. Int Wound J (2015). Jul 2019
Evidence in focus: IODOSORB™ 0.9 percent Cadexomer Iodine Gel...
Roche, et al. Int Wound J (2019). Apr 2019
IODOSORB™ Cadexomer Iodine supported better healing outcomes at 4 to...
O’Meara S, et al. Cochrane Database Syst Rev (2014). Feb 2019
The Past, Present and Future of Wound Care
Gregory Schultz (US). Dec 2017
The Impact of IODOSORB™ Against Biofilms in Diabetic Foot Ulcers
Dr Matthew Malone (AU). Dec 2017
2008 - 2021 Smith & Nephew Plc. ◊Trademark of Smith+Nephew Product information is for educational purposes only, and not all products or indications are licensed in every country.